Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 3K citations

Medicine, Oncology, Pharmacology +11

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text

Medicine, Molecular Biology, Oncology +14

High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number

Benjamin J. Hindson, Kevin D. Ness, Donald A Masquelier et al. · Analytical Chemistry · 2011 · 2.8K citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Identification of cells initiating human melanomas

Tobias Schatton, Gëorge F. Murphy, Natasha Y. Frank et al. · Nature · 2008 · 1.4K citations

Medicine, Cancer Biology, Oncology +12

Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Grant A. McArthur, Paul B. Chapman, Caroline Robert et al. · The Lancet Oncology · 2014 · 978 citations

Medicine, Oncology, Pharmacology +13